Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 3
2001 1
2002 2
2005 1
2006 1
2008 2
2010 3
2013 1
2017 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Definition of a factor Va binding site in factor Xa.
Rudolph AE, Porche-Sorbet R, Miletich JP. Rudolph AE, et al. Among authors: porche sorbet r. J Biol Chem. 2001 Feb 16;276(7):5123-8. doi: 10.1074/jbc.M006961200. Epub 2000 Nov 21. J Biol Chem. 2001. PMID: 11087737 Free article.
Gamma-glutamyl carboxylase and its influence on warfarin dose.
King CR, Deych E, Milligan P, Eby C, Lenzini P, Grice G, Porche-Sorbet RM, Ridker PM, Gage BF. King CR, et al. Among authors: porche sorbet rm. Thromb Haemost. 2010 Oct;104(4):750-4. doi: 10.1160/TH09-11-0763. Epub 2010 Aug 5. Thromb Haemost. 2010. PMID: 20694283 Free PMC article.
Population variation in VKORC1 haplotype structure.
Marsh S, King CR, Porche-Sorbet RM, Scott-Horton TJ, Eby CS. Marsh S, et al. Among authors: porche sorbet rm. J Thromb Haemost. 2006 Feb;4(2):473-4. doi: 10.1111/j.1538-7836.2006.01759.x. J Thromb Haemost. 2006. PMID: 16420583 Free article. No abstract available.
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators. Kimmel SE, et al. N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251361 Free PMC article. Clinical Trial.
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS. Gage BF, et al. Among authors: porche sorbet r. JAMA. 2019 Sep 3;322(9):834-842. doi: 10.1001/jama.2019.12085. JAMA. 2019. PMID: 31479138 Free PMC article. Clinical Trial.
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.
Voora D, Koboldt DC, King CR, Lenzini PA, Eby CS, Porche-Sorbet R, Deych E, Crankshaw M, Milligan PE, McLeod HL, Patel SR, Cavallari LH, Ridker PM, Grice GR, Miller RD, Gage BF. Voora D, et al. Among authors: porche sorbet r. Clin Pharmacol Ther. 2010 Apr;87(4):445-51. doi: 10.1038/clpt.2009.291. Epub 2010 Mar 3. Clin Pharmacol Ther. 2010. PMID: 20200517 Free PMC article.
18 results